Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**G antigen 12J (GAGE12J)** is a member of the GAGE (G antigen) family, a group of cancer/testis antigens encoded on the X chromosome and typically restricted in expression to germ cells in the testis and, aberrantly, to various tumor types[3][5][1]. The gene is protein-coding and highly homologous with other GAGE family members, e.g., GAGE12F and GAGE11[3][5][1]. These proteins are characterized as "dark proteins," with poorly understood structure and function, and tend to be short, have unusual amino acid composition, and few known protein interactions[1]. GAGE family proteins are generally not receptors, enzymes, or transporters, and there is no current evidence that GAGE12J functions as a classical drug or therapeutic target. However, like other cancer/testis antigens, GAGE12J may have a potential, though unproven, role as a biomarker or as a target for cancer immunotherapy research due to its expression pattern in cancers and immune-privileged tissues[1][5]. No drugs are currently known to interact specifically with GAGE12J.\n\nNote: This gene should not be confused with the "G antigen" of the blood group system, which is unrelated[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G antigen 12J (GAGE12J).